sameAs
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancerThe ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerPromoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerPrognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerFrequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysisWnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumoursRegulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicingPromoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerDeletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancerAberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosisALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroidsEndoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisationProtoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colonInfluence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cellsBDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression?Isolation and characterization of a 14.5-kDa trichloroacetic-acid-soluble translational inhibitor protein from human monocytes that is upregulated upon cellular differentiation.Autofluorescence imaging to optimize 5-ALA-induced fluorescence endoscopy of bladder carcinoma.Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.Photodynamic cystoscopy for detection of bladder tumors.Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts.Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosisNoncontact laser catapulting: a basic procedure for functional genomics and proteomics.Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor model.Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.Microdissection for detecting genetic aberrations in early and advanced human urinary bladder cancer.Laser microdissection for microsatellite analysis in colon and breast cancer.Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.Identifying prostate carcinoma by MALDI-Imaging.[Effective data collection in cancer research: an all-in-one database solution]Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue.Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.Serum proteomic profiling in patients with bladder cancer.Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression.
P50
Q21195213-FC1876F5-6BF0-43A4-A506-EBB7032148A7Q21195217-915582C6-ACBE-4444-B3D1-A11D6CD99003Q21245721-F0009DA1-C6C9-45F9-A616-D4EFC1732EC5Q21260388-6603E3E0-1239-42B5-8540-3D3986F68EFEQ21260401-3C4D9A7D-B0D8-49FE-8BF6-3AD743DC6A2AQ22000774-F0399380-C1C2-492D-9B64-6B25C07FF1C9Q24336664-A0FD639B-0110-46C2-ACBF-1A0DBB1C8A19Q24652213-5B02847F-B280-4900-8123-7BE6B6F809A9Q28245608-C519839B-9F46-41A8-A622-509432DB0465Q28294866-2DB3022F-5649-4659-9B3C-F30152446ECDQ28348222-6468C1D5-B06F-42F6-9CF9-25C047DFCA17Q28348624-0E94AF1B-C699-4B27-8868-48931D6115A0Q28364942-41C5BE25-4D1E-4760-A1E2-5F33CE932490Q28379164-EF6AD36D-EAA8-4BBC-8070-035027E66071Q28540922-8E60E805-DE53-4115-B2B1-F72BB5C3D36EQ29871512-98A9204C-10DD-47C1-92D5-28996DC23F66Q30713828-97D1C8C1-AEAA-4608-BE1A-713E21FEEFE6Q30729533-882EFD97-FC4F-418D-8650-27B256C6B92CQ30758261-CDF9D6FE-5DED-4B22-9455-BE465B4BF740Q31108376-0667798A-286C-4697-BA3C-A6F3F64BD35EQ31108584-74E496BE-2394-4484-91D3-1552897FCF36Q31108673-66632D58-F145-4F2A-9D29-968CB056ECD5Q33185104-407BBA55-08AB-48C0-9166-F3EEED275EC9Q33201598-A306DB4D-C81F-4D98-8586-B1CD31D45DE2Q33209616-B7B0857B-8365-42E7-8DB7-E927BFB63EC7Q33217204-38A9C37D-7911-49DB-B38A-9AA36493E6B6Q33219868-4144533A-8AF6-47F8-8858-2AA448852271Q33219869-B0442B8E-8940-4CFB-B8C5-B9576B1DF7BDQ33239315-E1415E30-D17F-4206-AE07-3428683DC66EQ33248745-10A88819-BB74-42CA-B254-D6FDFB742BDFQ33289967-51728F30-0CD4-47AB-98B9-B2821706F0DFQ33298933-C8B68E59-6F13-4A22-8EE5-2FEDE8EFBFE0Q33318574-D8A17E70-D2E8-435E-8C41-1BAD1ED63620Q33331648-1453CBAD-C9D5-4DAA-94C7-2401FE44F3AFQ33337458-8D907E09-90E9-4F81-AC21-BA2394F01017Q33385676-4AC6C858-69B5-4A53-AE8D-CDDA29623631Q33417500-8DF5E3FD-67A7-46E7-859B-89C1FB691346Q33481408-2F45CB7E-DC71-4BB7-9754-AED02D43C291Q33496580-2A1DB3E6-6CAB-456C-A1DD-250D6819DB32Q33515963-E9D94477-0D4C-4D25-8473-623289F87979
P50
description
Duits pathologe
@nl
German pathologist
@en
German pathologist
@en-ca
German pathologist
@en-gb
deutsche Pathologin und Hochschullehrerin
@de
patóloga alemana
@es
tysk professor
@da
tysk professor
@sv
عالمة أمراض ألمانية
@ar
name
Ruth Knüchel-Clarke
@ast
Ruth Knüchel-Clarke
@ca
Ruth Knüchel-Clarke
@cs
Ruth Knüchel-Clarke
@da
Ruth Knüchel-Clarke
@de
Ruth Knüchel-Clarke
@en
Ruth Knüchel-Clarke
@es
Ruth Knüchel-Clarke
@et
Ruth Knüchel-Clarke
@fi
Ruth Knüchel-Clarke
@fr
type
label
Ruth Knüchel-Clarke
@ast
Ruth Knüchel-Clarke
@ca
Ruth Knüchel-Clarke
@cs
Ruth Knüchel-Clarke
@da
Ruth Knüchel-Clarke
@de
Ruth Knüchel-Clarke
@en
Ruth Knüchel-Clarke
@es
Ruth Knüchel-Clarke
@et
Ruth Knüchel-Clarke
@fi
Ruth Knüchel-Clarke
@fr
altLabel
Knüchel-Clarke
@de
R Knuechel-Clarke
@en
R Knüchel-Clarke
@en
R. Knuechel-Clarke
@en
R. Knüchel-Clarke
@en
Ruth Knuchel-Clarke
@nl
Ruth Knuechel
@en
Ruth Knuechel-Clarke
@en
Ruth Knüchel
@en
Ruth Knüchel
@nl
prefLabel
Ruth Knüchel-Clarke
@ast
Ruth Knüchel-Clarke
@ca
Ruth Knüchel-Clarke
@cs
Ruth Knüchel-Clarke
@da
Ruth Knüchel-Clarke
@de
Ruth Knüchel-Clarke
@en
Ruth Knüchel-Clarke
@es
Ruth Knüchel-Clarke
@et
Ruth Knüchel-Clarke
@fi
Ruth Knüchel-Clarke
@fr
P214
P227
P1412
P1559
Ruth Knüchel-Clarke
@de
P19
P21
P214
P227
1081795956
P31
P4872
P496
0000-0002-4987-701X
P569
1959-05-02T00:00:00Z
P735
P7859
viaf-62163906